SelfAssay is a personal pharmacology intelligence platform designed for individuals interested in biohacking, longevity, and managing complex supplement or medication regimens. The platform enables users to approach their supplement, peptide, or longevity compound stacks with scientific rigor, providing tools to research, grade, and measure the effectiveness and safety of each component. Users can run their "stack like a lab," leveraging both personal and community data to inform their decisions.
A core feature of SelfAssay is its grading system, which assigns three distinct grades to each compound: one based on community reports, another on clinical trial conclusions, and a third on safety. Each claim is cited, and the platform refuses to provide information that cannot be substantiated. Users can track a variety of biomarkers—up to 11 are mentioned—using lab and blood data to establish baselines and monitor changes over time. The platform draws on a knowledge graph built from classified user reports, peer-reviewed literature, and clinical data, including thousands of real-world reports and hundreds of studies. This evidence-based approach is intended to replace guesswork with grounded answers, explicitly naming uncertainties and cohort sizes.
SelfAssay is web-based and emphasizes user privacy and control. Data is encrypted and member-owned, with options to export or delete personal information at any time. The platform provides decision support through features that synthesize scattered protocols and bloodwork into actionable insights, but it does not offer medical advice. It is free to start, allowing users to explore its capabilities before committing further.
The tool is positioned as an operating system for managing personal supplement and medication stacks, catering to users who demand scientific rigor and transparency. Its focus on cited evidence, user ownership, and comprehensive tracking distinguishes it within the health-fitness technology space.
In the Health & fitness space, SelfAssay takes a focused approach. Helping users make informed decisions about supplements and longevity compounds by tracking effects and analyzing data. It is built as a consumer product for biohackers and health enthusiasts. SelfAssay follows a freemium model, with paid plans starting at $19. It runs on the web.
Behind SelfAssay is SelfAssay, and the product first shipped in 2024. Key capabilities include supplement tracking, biomarker analysis, and community reports.
Latest indexed changes and source events
Show HN: Personal Biohacking Lab verified by the PulseGate indexer
Other apps tracked under the same category.
